Literature DB >> 17626650

The role of squamous differentiation in patients with transitional cell carcinoma of the bladder treated with radical cystectomy.

Alberto A Antunes1, Luciano J Nesrallah, Marcos F Dall'Oglio, Carlos E Maluf, Cesar Camara, Katia R Leite, Miguel Srougi.   

Abstract

OBJECTIVE: We aim at determining the prognostic value of squamous differentiation in patients with transitional cell carcinoma (TCC) of the bladder that were treated with radical cystectomy.
MATERIALS AND METHODS: From January 1993 to January 2005, we retrospectively selected 113 patients. Correlations among squamous differentiation with other clinical and pathological features were assessed by both chi-square and Fisher tests. The Kaplan-Meier method was used to evaluate survival curves and statistical significance was determined by the log-rank test. Multivariate analysis was performed through a Cox proportional hazards regression model.
RESULTS: Squamous differentiation was observed in 25 (22.1%) of the 113 patients. This finding was significantly related only to the pathological stage. Mean follow-up after cystectomy was 31.7 +/- 28.5 months. Disease recurrence occurred in 16 (64%) and 30 (34%) patients with and without squamous differentiation (log-rank test, p = 0.001), and mortality occurred in 10 (40%) and 14 (16%) of the patients with and without squamous differentiation respectively. Univariate analysis revealed that pathological stage, squamous differentiation, tumor size and lymph node involvement were significant predictors of cancer-specific survival. However, only squamous differentiation and tumor size were independent prognostic variables on multivariate analysis.
CONCLUSIONS: Squamous differentiation was an independent prognostic factor for cancer specific survival in patients with bladder cancer treated with radical cystectomy. Further studies with a larger number of patients are necessary to confirm these results.

Entities:  

Mesh:

Year:  2007        PMID: 17626650     DOI: 10.1590/s1677-55382007000300006

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN: 1677-5538            Impact factor:   1.541


  28 in total

Review 1.  Variant forms of bladder cancer: basic considerations on treatment approaches.

Authors:  Francesc Pons; Anna Orsola; Juan Morote; Joaquim Bellmunt
Journal:  Curr Oncol Rep       Date:  2011-06       Impact factor: 5.075

2.  Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.

Authors:  Behfar Ehdaie; Alexandra Maschino; Shahrokh F Shariat; Jorge Rioja; Robert J Hamilton; William T Lowrance; Stephen A Poon; Hikmat A Al-Ahmadie; Harry W Herr
Journal:  J Urol       Date:  2011-11-16       Impact factor: 7.450

3.  Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer.

Authors:  Venu Chalasani; Joseph L Chin; Jonathan I Izawa
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

Review 4.  [Squamous cell lesions of the urinary bladder].

Authors:  S Rausch; N Gaisa; R F Youssef; Y Lotan; A Stenzl; T Kälble
Journal:  Urologe A       Date:  2014-03       Impact factor: 0.639

5.  Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.

Authors:  Chia-En Li; Chia-Shen Chien; Yao-Chi Chuang; Ye-In Chang; Hsiu-Pei Tang; Chih-Hsiung Kang
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

6.  Urothelial eddies in papillary urothelial neoplasms: a distinct morphologic pattern with low risk for progression.

Authors:  Misung Kim; Jae Y Ro; Mahul B Amin; Mariza de Peralta-Venturina; Ghee Young Kwon; Yong Wook Park; Yong Mee Cho
Journal:  Int J Clin Exp Pathol       Date:  2013-07-15

7.  Squamous differentiation and prognosis in upper urinary tract urothelial carcinoma.

Authors:  Naohiro Makise; Teppei Morikawa; Taketo Kawai; Tohru Nakagawa; Haruki Kume; Yukio Homma; Masashi Fukayama
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

8.  Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study.

Authors:  Natalie J Miller; Ali Raza Khaki; Leonidas N Diamantopoulos; Mehmet A Bilen; Victor Santos; Neeraj Agarwal; Rafael Morales-Barrera; Michael Devitt; Ariel Nelson; Christopher J Hoimes; Evan Shreck; Hussein Assi; Benjamin A Gartrell; Alex Sankin; Alejo Rodriguez-Vida; Mark Lythgoe; David J Pinato; Alexandra Drakaki; Monika Joshi; Pedro Isaacsson Velho; Noah Hahn; Sandy Liu; Lucia Alonso Buznego; Ignacio Duran; Marcus Moses; Jayanshu Jain; Jure Murgic; Pedro Barata; Abhishek Tripathi; Yousef Zakharia; Matthew D Galsky; Guru Sonpavde; Evan Y Yu; Gary H Lyman; Petros Grivas
Journal:  J Urol       Date:  2020-01-23       Impact factor: 7.450

9.  Prognostic significance of mucin expression in urothelial bladder cancer.

Authors:  Slavica Stojnev; Ana Ristic-Petrovic; Ljubinka Jankovic Velickovic; Miljan Krstic; Dragan Bogdanovic; Do Throng Khanh; Ana Ristic; Irena Conic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Analysis of the clinicopathological characteristics of patients with upper urinary tract transitional cell carcinoma.

Authors:  Claudio B Murta; Alberto A Antunes; Marcos F Dall'Oglio; Alcides Mosconi; Kátia R Leite; Miguel Srougi
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.